Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:
Consumer OTC Drugs

McNeil Gelatin Capsules Patent Infringed By Bayer, Jury Says

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Two gelcap formulations of Bayer aspirin infringe a McNeil-PPC patent covering dual-colored, gelatin-coated caplets, a jury concluded July 26

You may also be interested in...



McNeil gelcaps patent

Firm's OTCs that use gelatin capsule technology covered by '524 patent include Tylenol cough/cold products, not cough/cold offerings under the Motrin brand, as incorrectly stated in 1"The Tan Sheet" Aug. 5, 2002, p. 13...

McNeil gelcaps patent

Firm's OTCs that use gelatin capsule technology covered by '524 patent include Tylenol cough/cold products, not cough/cold offerings under the Motrin brand, as incorrectly stated in 1"The Tan Sheet" Aug. 5, 2002, p. 13...

McNeil gelcaps patent

Firm's OTCs that use gelatin capsule technology covered by '524 patent include Tylenol cough/cold products, not cough/cold offerings under the Motrin brand, as incorrectly stated in 1"The Tan Sheet" Aug. 5, 2002, p. 13...

Table

View full table

Topics

Tags:
Consumer OTC Drugs
UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By